SeeMedX
SeeMedX is dedicated to saving lives through non-invasive detection and prevention of life-threatening conditions, especially focusing on heart failure. They develop advanced cardiac monitoring systems utilizing bioimpedance technology to provide real-time, accurate data to healthcare professionals, aiming to improve patient outcomes and transform cardiac care.
Industries
Nr. of Employees
small (1-50)
SeeMedX
6280 S. Valley View Blvd. Suite 632, Las Vegas, NV 89118
Patents
Products
Non-invasive cardiac monitoring device (bioimpedance-based)
A non-invasive monitor that measures thoracic impedance and impedance-derived waveforms synchronized with ECG to provide continuous estimates of cardiac output, stroke volume, and thoracic fluid status for clinical monitoring and decision support.
Non-invasive cardiac monitoring device (bioimpedance-based)
A non-invasive monitor that measures thoracic impedance and impedance-derived waveforms synchronized with ECG to provide continuous estimates of cardiac output, stroke volume, and thoracic fluid status for clinical monitoring and decision support.
Services
Sponsorship and collaborative research with university health systems and research institutions to evaluate non-invasive hemodynamic monitoring methods and publish results.
Point of contact for sales, ordering, product support, and reimbursement guidance for non-invasive monitoring devices.
Online condition-focused educational content for patients and caregivers covering hypertension, deep vein thrombosis, diagnosis methods, lifestyle interventions, and prevention strategies.
Sponsorship and collaborative research with university health systems and research institutions to evaluate non-invasive hemodynamic monitoring methods and publish results.
Point of contact for sales, ordering, product support, and reimbursement guidance for non-invasive monitoring devices.
Online condition-focused educational content for patients and caregivers covering hypertension, deep vein thrombosis, diagnosis methods, lifestyle interventions, and prevention strategies.
Expertise Areas
- Non-invasive hemodynamic monitoring
- Cardiac monitoring and heart failure management
- Telehealth and remote patient monitoring
- Regulatory submissions and medical device clearance (FDA 510(k))
Key Technologies
- Thoracic bioimpedance (impedance cardiography)
- ECG-synchronized beat-to-beat waveform analysis
- Real-time cardiac output estimation
- Impedance-derived thoracic fluid assessment
News & Updates
SeeMedX submitted a 510(k) premarket notification to the FDA for a non-invasive cardiac monitoring device designed to provide real-time insights into cardiac performance and fluid status, aiming to improve heart failure care.
Dr. Ganz, a leader in cardiology and clinical cardiac research, joins the advisory board to help guide the development of non-invasive cardiac monitoring technology to predict cardiac events before they happen.
SeeMedX submitted a 510(k) premarket notification to the FDA for a non-invasive cardiac monitoring device designed to provide real-time insights into cardiac performance and fluid status, aiming to improve heart failure care.
Dr. Ganz, a leader in cardiology and clinical cardiac research, joins the advisory board to help guide the development of non-invasive cardiac monitoring technology to predict cardiac events before they happen.